As recent studies have shown alterations of GGA1 and GGA3 protein levels in postmortem samples of AD patients, we also compared the expression of GGA2 in 26 temporal lobe samples obtained from control and AD patients. The gene discussed is GGA3; the disease is Alzheimer disease.